Diabetic medicine. Study uncovers why COVID is more deadly fo | EurekAlert!
It found that type 2 diabetes is associated with a higher risk of mortality in hospitalised COVID patients than type 1 diabetes.
The combination of an older age and high C-reactive protein CRP was also linked to a higher risk of death. Younger people under 70 years old with chronic kidney disease, a common long-term complication of diabetes, also had a higher likelihood of dying.
Modeling long-term diabetes and related complications in rats J Pharmacol Toxicol Methods. Mar-Apr ; Epub Nov Gyömrői út Electronic address: erika.
BMI, however, was not linked to survival. The information has been used to create a simple model which can be used to predict which patients are at higher risk of death.
While people with diabetes are diabetic medicine more likely to contract COVID than others, they diabetic medicine more likely to become severely ill if they diabetic medicine catch it. It has been unclear, however, if certain characteristics put some people with diabetes at higher risk of serious illness and death than others.
The 1, patients from seven hospitals in northwest England had an average age of Most Median BMI was The greater socio-economic deprivation and older age of the patients studied may help explain why the seven-day mortality was higher than in other studies, says Dr Llanera. However, further research is needed to confirm this.
Approximately one in ten patients 9. Analysis showed that those with type 2 diabetes were 2.
Risk of death was also higher among unders with chronic kidney 1es típusú cukorbetegség. They were 2. This may lead to direct attack of the kidneys by the virus, possibly leading to worse overall outcomes.
The data has used to create a model, which, if applied to a patient with similar demographic characteristics, can predict a higher risk of death in 7 days using only age and CRP as variables. This means we can easily identify patients early on their hospital stay who will likely require more aggressive interventions to try and improve survival.
Nor was any significant association seen with diabetes complications, other than chronic kidney disease, or use of ACE inhibitors and angiotensin receptor blockers ARBs - types of blood pressure drugs. The proportion of patients 9.
Protective effects of the novel amine-oxidase inhibitor multi-target drug SZV on streptozotocin-induced beta cell damage and diabetic complications in rats Biomed Pharmacother. Epub Dec Electronic address: zsuzsanna. DOI: Amine oxidase copper containing 3 AOC3 is an enzyme that belongs to the semicarbazide-sensitive amine oxidase family, which may be a novel therapeutic target to treat diabetic complications.